- Home
- TIL vs EML Comparison
TIL vs EML Comparison
Compare TIL & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- EML
- Stock Information
- Founded
- TIL 2018
- EML 1858
- Country
- TIL United States
- EML United States
- Employees
- TIL N/A
- EML N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- EML Industrial Machinery/Components
- Sector
- TIL Health Care
- EML Consumer Discretionary
- Exchange
- TIL Nasdaq
- EML Nasdaq
- Market Cap
- TIL 177.1M
- EML 144.5M
- IPO Year
- TIL 2021
- EML N/A
- Fundamental
- Price
- TIL $27.84
- EML $21.52
- Analyst Decision
- TIL Buy
- EML
- Analyst Count
- TIL 6
- EML 0
- Target Price
- TIL $120.50
- EML N/A
- AVG Volume (30 Days)
- TIL 159.0K
- EML 9.1K
- Earning Date
- TIL 08-13-2025
- EML 08-05-2025
- Dividend Yield
- TIL N/A
- EML 2.04%
- EPS Growth
- TIL N/A
- EML N/A
- EPS
- TIL N/A
- EML N/A
- Revenue
- TIL N/A
- EML $269,054,445.00
- Revenue This Year
- TIL N/A
- EML $1.56
- Revenue Next Year
- TIL N/A
- EML $7.00
- P/E Ratio
- TIL N/A
- EML $12.04
- Revenue Growth
- TIL N/A
- EML 1.30
- 52 Week Low
- TIL $9.90
- EML $19.06
- 52 Week High
- TIL $92.00
- EML $35.03
- Technical
- Relative Strength Index (RSI)
- TIL 52.43
- EML 38.49
- Support Level
- TIL $25.79
- EML $22.21
- Resistance Level
- TIL $29.67
- EML $24.28
- Average True Range (ATR)
- TIL 2.62
- EML 0.69
- MACD
- TIL 0.10
- EML -0.01
- Stochastic Oscillator
- TIL 70.92
- EML 0.72
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.